APA ציטוט

Wu, J., Fu, J., Zhang, M., & Liu, D. (2015). Blinatumomab: A bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia. J Hematol Oncol.

Citação norma Chicago

Wu, Jingjing, Jiaping Fu, Mingzhi Zhang, and Delong Liu. "Blinatumomab: A Bispecific T Cell Engager (BiTE) Antibody against CD19/CD3 for Refractory Acute Lymphoid Leukemia." J Hematol Oncol 2015.

ציטוט MLA

Wu, Jingjing, Jiaping Fu, Mingzhi Zhang, and Delong Liu. "Blinatumomab: A Bispecific T Cell Engager (BiTE) Antibody against CD19/CD3 for Refractory Acute Lymphoid Leukemia." J Hematol Oncol 2015.